Symbol | Exchange | Currency |
|---|
Adaptive Biotechnologies (NASDAQ:ADPT) Corporation (Nasdaq: ADPT) today announced that the U.S. Food and Drug Administration has accepted an investigational new drug (IND)...
Investing.com - Adaptive Biotechnologies (NASDAQ: ADPT) reported first quarter EPS of $-0.40, $0.03 worse than the analyst estimate of $-0.37. Revenue for the quarter came in at...
Exact Sciences (NASDAQ:EXAS) EXAS is the $19 billion leader in proactive cancer diagnostics with the Cologuard screening kit, which the majority of healthcare providers are...
There was no Friday rally this time around as stocks took a step back today and finished the week lower amid ongoing concerns of rising inflation. Even better-than-expected...
There was no Friday rally this time around as stocks took a step back today and finished the week lower amid ongoing concerns of rising inflation. Even better-than-expected...
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on using the biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine (IM) platform combines a suite of chemistry, computational biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its clinical diagnostic product, clonoSEQ, is used for the detection and monitoring minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL). The IM business consists of two areas: IM Pharma Services and Drug Discovery. Its immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA).
| Average | 12.29 (+66.70% Upside) |
| High | 15.00 |
| Low | 7.00 |
| Price | 7.37 |
| No. of Analysts | 7 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Sell | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.79 | 7.89 | 7.60 | +0.03 | +0.39% | 62.85M | NYSE | |||
| 92.53 | 92.68 | 91.30 | +0.01 | +0.01% | 8.98M | NYSE | |||
| 8.64 | 8.72 | 8.43 | +0.130 | +1.53% | 3.14M | NYSE | |||
| 4.69 | 5.00 | 4.56 | -0.1600 | -3.30% | 643.34K | NASDAQ | |||
| 23.63 | 23.67 | 23.36 | +0.23 | +0.98% | 2.96M | NASDAQ | |||
| 9.13 | 9.52 | 9.07 | -0.33 | -3.49% | 137.26K | NASDAQ | |||
| 1.32 | 1.3596 | 1.31 | -0.0200 | -1.49% | 45.25K | NASDAQ | |||
| 122.67 | 123.73 | 122.01 | -0.27 | -0.22% | 24.29M | NASDAQ | |||
| 12.08 | 12.24 | 11.95 | -0.18 | -1.47% | 346.87K | NYSE | |||
| 63.02 | 64.72 | 62.96 | -1.83 | -2.82% | 4.37M | NYSE | |||
| 100.96 | 101.00 | 100.94 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 13.10 | 13.30 | 12.91 | -0.25 | -1.87% | 139.82K | NYSE | |||
| 25.35 | 25.37 | 25.35 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 59.59 | 60.41 | 59.00 | -0.99 | -1.63% | 107.98K | NASDAQ | |||
| 13.21 | 13.24 | 12.83 | +0.51 | +4.02% | 155.98K | OTC Markets |